Retrieve Medical Holdings Price to Book Ratio 2012-2025 | RMHI
Historical price to book ratio values for Retrieve Medical Holdings (RMHI) over the last 10 years. The current price to book ratio for Retrieve Medical Holdings as of January 23, 2026 is 0.00.
| Retrieve Medical Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-22 | 2.44 | 0.00 | |
| 2025-09-30 | 1.30 | $-0.18 | -7.30 |
| 2025-06-30 | 1.08 | $-0.17 | -6.32 |
| 2025-03-31 | 4.50 | $-0.19 | -23.14 |
| 2024-12-31 | 1.07 | 0.00 | |
| 2024-09-30 | 2.57 | $-0.19 | -13.44 |
| 2024-06-30 | 2.20 | $-0.21 | -10.64 |
| 2024-03-31 | 3.70 | $-0.18 | -20.98 |
| 2023-12-31 | 1.73 | $-0.16 | -10.82 |
| 2023-09-30 | 3.95 | $-0.16 | -24.41 |
| 2023-06-30 | 2.75 | $-0.16 | -17.12 |
| 2022-12-31 | 27.60 | $-5.51 | -5.01 |
| 2022-09-30 | 12.00 | $-1.25 | -9.57 |
| 2022-06-30 | 11.00 | $-1.10 | -9.99 |
| 2022-03-31 | 16.00 | $-1.12 | -14.25 |
| 2021-12-31 | 16.20 | $-0.98 | -16.46 |
| 2021-09-30 | 26.00 | 0.00 | |
| 2021-06-30 | 23.40 | $-0.82 | -28.71 |
| 2021-03-31 | 28.00 | $-0.77 | -36.55 |
| 2020-12-31 | 16.60 | $-0.66 | -25.26 |
| 2020-09-30 | 2.40 | 0.00 | |
| 2020-06-30 | 3.00 | $-0.63 | -4.78 |
| 2020-03-31 | 2.80 | $-0.62 | -4.53 |
| 2019-12-31 | 2.60 | $-0.61 | -4.27 |
| 2019-09-30 | 2.40 | 0.00 | |
| 2019-06-30 | 7.40 | $-0.59 | -12.54 |
| 2019-03-31 | 18.60 | $-0.58 | -32.02 |
| 2018-12-31 | 24.00 | $-0.57 | -41.99 |
| 2018-09-30 | 25.00 | 0.00 | |
| 2018-06-30 | 28.80 | $-0.55 | -52.71 |
| 2018-03-31 | 17.80 | $-0.54 | -33.26 |
| 2017-12-31 | 30.00 | $-0.51 | -58.69 |
| 2017-09-30 | 5.80 | 0.00 | |
| 2017-06-30 | 7.40 | $-0.43 | -17.21 |
| 2017-03-31 | 11.20 | $-0.39 | -28.54 |
| 2016-12-31 | 8.00 | $-0.37 | -21.87 |
| 2016-09-30 | 6.00 | 0.00 | |
| 2016-06-30 | 3.40 | $-0.35 | -9.70 |
| 2016-03-31 | 2.40 | $-0.33 | -7.37 |
| 2015-12-31 | 5.40 | $-0.11 | -51.38 |
| 2015-09-30 | 10.00 | 0.00 | |
| 2015-06-30 | 23.20 | $0.20 | 116.52 |
| 2015-03-31 | 46.00 | $0.42 | 109.94 |
| 2014-12-31 | 39.60 | $0.71 | 55.56 |
| 2014-09-30 | 102.00 | 0.00 | |
| 2014-06-30 | 188.00 | $0.62 | 305.19 |
| 2014-03-31 | 244.00 | $-1.50 | -162.23 |
| 2013-12-31 | 0.02 | $-0.99 | -0.02 |
| 2011-03-31 | 0.00 | $0.08 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.067B | $0.000B |
| Retrieve Medical Inc. is a software company. It is commercializing a patented Clinical Documentation Improvement platform, Retrieve Dx(TM), which enhances physician ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more. Retrieve Medical Inc., formerly known as Peak Pharmaceuticals Inc., is based in SCOTTSDALE, AZ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.032B | 42.83 |
| Tempus AI (TEM) | United States | $12.162B | 0.00 |
| Doximity (DOCS) | United States | $7.681B | 31.63 |
| Hims & Hers Health (HIMS) | United States | $6.948B | 56.52 |
| IRhythm Holdings (IRTC) | United States | $5.309B | 0.00 |
| Hinge Health (HNGE) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.947B | 184.31 |
| 10x Genomics (TXG) | United States | $2.935B | 0.00 |
| Heartflow (HTFL) | United States | $2.853B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.348B | 38.85 |
| Omnicell (OMCL) | United States | $2.303B | 47.08 |
| Azenta (AZTA) | United States | $1.886B | 77.38 |
| Clover Health Investments (CLOV) | United States | $1.385B | 0.00 |
| Enovis (ENOV) | United States | $1.347B | 7.07 |
| Schrodinger (SDGR) | United States | $1.277B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.187B | 0.00 |
| Phreesia (PHR) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.871B | 0.00 |
| Talkspace (TALK) | United States | $0.658B | 132.33 |
| Standard BioTools (LAB) | United States | $0.619B | 0.00 |
| Claritev (CTEV) | United States | $0.497B | 0.00 |
| Evolent Health (EVH) | United States | $0.429B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.373B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.326B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.31 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| CapsoVision (CV) | United States | $0.293B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.263B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.196B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.130B | 7.12 |
| Outset Medical (OM) | United States | $0.098B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.060B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.035B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |